Current and historical daily PE Ratio for G Medical Innovations Holdings Ltd (
FRA:9GM0
) from 2017 to Jun 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. G Medical Innovations stock (FRA:9GM0) PE ratio as of Jun 24 2024 is 0.
More Details
G Medical Innovations Holdings Ltd (FRA:9GM0) PE Ratio (TTM) Chart
G Medical Innovations Holdings Ltd (FRA:9GM0) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 1084
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| G Medical Innovations PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-24 | At Loss | 2023-07-04 | At Loss |
| 2023-09-05 | At Loss | 2023-07-03 | At Loss |
| 2023-09-04 | At Loss | 2023-06-30 | At Loss |
| 2023-09-01 | At Loss | 2023-06-29 | At Loss |
| 2023-08-31 | At Loss | 2023-06-28 | At Loss |
| 2023-08-30 | At Loss | 2023-06-27 | At Loss |
| 2023-08-29 | At Loss | 2023-06-26 | At Loss |
| 2023-08-28 | At Loss | 2023-06-23 | At Loss |
| 2023-08-25 | At Loss | 2023-06-22 | At Loss |
| 2023-08-24 | At Loss | 2023-06-21 | At Loss |
| 2023-08-22 | At Loss | 2023-06-20 | At Loss |
| 2023-08-21 | At Loss | 2023-06-19 | At Loss |
| 2023-08-18 | At Loss | 2023-06-16 | At Loss |
| 2023-08-17 | At Loss | 2023-06-15 | At Loss |
| 2023-08-16 | At Loss | 2023-06-14 | At Loss |
| 2023-08-15 | At Loss | 2023-06-13 | At Loss |
| 2023-08-14 | At Loss | 2023-06-12 | At Loss |
| 2023-08-11 | At Loss | 2023-06-09 | At Loss |
| 2023-08-10 | At Loss | 2023-06-08 | At Loss |
| 2023-08-09 | At Loss | 2023-06-07 | At Loss |
| 2023-08-08 | At Loss | 2023-06-06 | At Loss |
| 2023-08-07 | At Loss | 2023-06-05 | At Loss |
| 2023-08-04 | At Loss | 2023-06-02 | At Loss |
| 2023-08-03 | At Loss | 2023-06-01 | At Loss |
| 2023-08-02 | At Loss | 2023-05-30 | At Loss |
| 2023-08-01 | At Loss | 2023-05-29 | At Loss |
| 2023-07-31 | At Loss | 2023-05-26 | At Loss |
| 2023-07-28 | At Loss | 2023-05-25 | At Loss |
| 2023-07-27 | At Loss | 2023-05-24 | At Loss |
| 2023-07-26 | At Loss | 2023-05-22 | At Loss |
| 2023-07-25 | At Loss | 2023-05-19 | At Loss |
| 2023-07-24 | At Loss | 2023-05-18 | At Loss |
| 2023-07-21 | At Loss | 2023-05-17 | At Loss |
| 2023-07-20 | At Loss | 2023-05-16 | At Loss |
| 2023-07-19 | At Loss | 2023-05-15 | At Loss |
| 2023-07-18 | At Loss | 2023-05-12 | At Loss |
| 2023-07-17 | At Loss | 2023-05-11 | At Loss |
| 2023-07-14 | At Loss | 2023-05-10 | At Loss |
| 2023-07-13 | At Loss | 2023-05-09 | At Loss |
| 2023-07-12 | At Loss | 2023-05-08 | At Loss |
| 2023-07-11 | At Loss | 2023-05-05 | At Loss |
| 2023-07-10 | At Loss | 2023-05-04 | At Loss |
| 2023-07-07 | At Loss | 2023-05-03 | At Loss |
| 2023-07-06 | At Loss | 2023-05-02 | At Loss |
| 2023-07-05 | At Loss | 2023-04-28 | At Loss |
G Medical Innovations Holdings Ltd (FRA:9GM0) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
G Medical Innovations Holdings Ltd
ISIN : KYG394621091
Description
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers